Mitochondrial Stress Links Environmental Triggers with Pro-Inflammatory Signaling in Crohn’s Disease

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Inflammatory Bowel Diseases (IBD) are a group of chronic, inflammatory disorders of the gut. The incidence and activity of IBD are determined by both genetic and environmental factors. Among these factors, polymorphisms in genes related to autophagy and the consumption of non-steroidal anti-inflammatory drugs (NSAIDs) have been consistently associated with IBD. We show that NSAIDs induce mitochondrial stress and mitophagy in intestinal epithelial cells. In an altered mitophagy context simulating that observed in IBD patients, NSAID-induced mitochondrial stress leads to the release of mitochondrial components, which act as Danger Associated Molecular Patterns with pro-inflammatory potential. Furthermore, colonic organoids from Crohn’s disease patients and healthy donors show activation of the mitochondrial Unfolded Protein Response (UPRmt) upon treatment with ibuprofen. Finally, colon biopsies from Crohn’s disease patients in remission or with low-to-moderate activity also show expression of genes involved in UPRmt, while patients with severe activity show no increase compared to healthy donors. Our results suggest the involvement of mitochondria in the mechanisms triggering inflammation in IBD after NSAID use. Moreover, our results highlight the clinical relevance of mitochondrial stress and activation of the UPRmt pathway in the pathophysiology of Crohn’s disease.
Funding Information
  • Ministerio de Ciencia, Innovación y Universidades (IJCI-2017-31466, PI18/01652, UMA20-FEDERJA-081, PI-0244-2021, CP22/00050, RC-0005-2020, FI19/00189, CP18/00042, CD21/00198, IJC2018-037657-I, DOC_01610)
  • Instituto de Salud Carlos III (IJCI-2017-31466, PI18/01652, UMA20-FEDERJA-081, PI-0244-2021, CP22/00050, RC-0005-2020, FI19/00189, CP18/00042, CD21/00198, IJC2018-037657-I, DOC_01610)
  • FEDER funds/Consejería de Economía y Conocimiento, Empresas y Universidad de la Junta de Andalucía (IJCI-2017-31466, PI18/01652, UMA20-FEDERJA-081, PI-0244-2021, CP22/00050, RC-0005-2020, FI19/00189, CP18/00042, CD21/00198, IJC2018-037657-I, DOC_01610)
  • Consejería de Salud y Familia de la Junta de Andalucía (IJCI-2017-31466, PI18/01652, UMA20-FEDERJA-081, PI-0244-2021, CP22/00050, RC-0005-2020, FI19/00189, CP18/00042, CD21/00198, IJC2018-037657-I, DOC_01610)
  • European Union (IJCI-2017-31466, PI18/01652, UMA20-FEDERJA-081, PI-0244-2021, CP22/00050, RC-0005-2020, FI19/00189, CP18/00042, CD21/00198, IJC2018-037657-I, DOC_01610)
  • Nicolas Monardes program from the Consejería de Salud de Andalucía (IJCI-2017-31466, PI18/01652, UMA20-FEDERJA-081, PI-0244-2021, CP22/00050, RC-0005-2020, FI19/00189, CP18/00042, CD21/00198, IJC2018-037657-I, DOC_01610)
  • ISCIII (IJCI-2017-31466, PI18/01652, UMA20-FEDERJA-081, PI-0244-2021, CP22/00050, RC-0005-2020, FI19/00189, CP18/00042, CD21/00198, IJC2018-037657-I, DOC_01610)
  • Ministerio de Ciencia e Innovación (IJCI-2017-31466, PI18/01652, UMA20-FEDERJA-081, PI-0244-2021, CP22/00050, RC-0005-2020, FI19/00189, CP18/00042, CD21/00198, IJC2018-037657-I, DOC_01610)
  • Industria, Conocimiento y Universidades de Junta de Andalucía (IJCI-2017-31466, PI18/01652, UMA20-FEDERJA-081, PI-0244-2021, CP22/00050, RC-0005-2020, FI19/00189, CP18/00042, CD21/00198, IJC2018-037657-I, DOC_01610)

This publication has 35 references indexed in Scilit: